![Vijay Kuchroo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Kuchroo
Directeur/Membre du Conseil chez
Evergrande Centre For Immunologic Diseases
Profil
Vijay Kumar Kuchroo is the founder of Celsius Therapeutics, Inc., founded in 2018.
Dr. Kuchroo is also the founder of CoStim Pharmaceuticals, Inc.,Tempero Pharmaceuticals, Inc.,Tizona Therapeutics, Inc.,Larkspur Biosciences, Inc. Dr. Kuchroo currently serves as Director at Massachusetts Institute of Technology and Evergrande Centre For Immunologic Diseases.
Dr. Kuchroo is Co-Director-Infection & Immunity at Brigham Research Institute.
Dr. Kuchroo is Founding Director at Mass General Hospital.
Dr. Kuchroo is Member-Scientific Advisory Board at Potenza Therapeutics, Inc. Dr. Kuchroo is a Member at The Broad Institute, Inc. Dr. Kuchroo is Professor at Harvard Medical School.
Dr. Kuchroo is Venture Partner at Catalio Capital Management LP.
Former positions include Independent Non-Executive Director at Biocon Ltd. from 2015 to 2023, Independent Non-Executive Director at Syngene International Ltd., Independent Director at Bicara Therapeutics, Inc., and Senior Scientist at The Brigham & Women's Hospital, Inc. Education includes a doctorate from The University of Queensland conferred in 1985 and an undergraduate degree from Haryana Agricultural University conferred in 1976.
Postes actifs de Vijay Kuchroo
| Sociétés | Poste | Début |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Evergrande Centre For Immunologic Diseases | Directeur/Membre du Conseil | - |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Corporate Officer/Principal | - |
Brigham Research Institute | Corporate Officer/Principal | - |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Directeur/Membre du Conseil | - |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Directeur/Membre du Conseil | - |
Mass General Hospital | Corporate Officer/Principal | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Anciens postes connus de Vijay Kuchroo
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCON LIMITED | Directeur/Membre du Conseil | 26/07/2023 |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Vijay Kuchroo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Health Technology |
Biocon Ltd.
 Biocon Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Syngene International Ltd.
 Syngene International Ltd. Miscellaneous Commercial ServicesCommercial Services Offers integrated discovery and development services | Commercial Services |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Tempero Pharmaceuticals, Inc.
 Tempero Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develop next-generation therapies that selectively suppress Th17-cells and enhance specialized Treg cells | Commercial Services |
Evergrande Centre For Immunologic Diseases | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Brigham Research Institute | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Mass General Hospital | |
Haryana Agricultural University
 Haryana Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Larkspur Biosciences, Inc.
 Larkspur Biosciences, Inc. BiotechnologyHealth Technology Develops immunotherapies to outsmart cancer | Health Technology |
